![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 471/04 | (2006.01) |
A61K 31/437 | (2006.01) |
(11) | Number of the document | 1761529 |
(13) | Kind of document | T |
(96) | European patent application number | 05751627.0 |
Date of filing the European patent application | 2005-06-16 | |
(97) | Date of publication of the European application | 2007-03-14 |
(45) | Date of publication and mention of the grant of the patent | 2007-11-14 |
(46) | Date of publication of the claims translation | 2008-03-26 |
(86) | Number | PCT/EP2005/006493 |
Date | 2005-06-16 |
(87) | Number | WO 2005/123731 |
Date | 2005-12-29 |
(30) | Number | Date | Country code |
0413619 | 2004-06-17 | GB | |
0507693 | 2005-04-15 | GB |
(72) |
BALA, Kamlesh, Novartis Horsham Research Centre, GB
LEBLANC, Catherine, Novartis Horsham Research Ctr., GB
SANDHAM, David Andrew, Novartis Horsham Res. Ctr., GB
TURNER, Katharine L., Novartis Horsham Res. Ctr., GB
WATSON, Simon James, Novartis Horsham Res. Ctr., GB
BROWN, Lyndon Nigel, GB
COX, Brian, Novartis Horsham Res. Ctr, GB
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pirolopiridino dariniai ir jų, kaip CRTH2 antagonistų, panaudojimas |
PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS |
Payment date | Validity (years) | Amount | |
2022-06-13 | 18 | 347.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2023-06-16 |